Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J K Rees

Showing results (31-40 of 40) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 40 results.
British Journal of Haematology|February 1, 1984
8;21 translocation in acute granulocytic leukaemia: cytological, cytochemical and clinical featuresD M Swirsky, Y S Li, J G Matthews, et al.
Blood|April 1, 1997
Randomized comparison of DAT versus ADE as induction chemotherapy in children and younger adults with acute myeloid leukemia. Results of the Medical Research Council's 10th AML trial (MRC AML10). Adult and Childhood Leukaemia Working Parties of the Medical Research CouncilI M Hann, R F Stevens, A H Goldstone, et al.
Lancet (London, England)|March 21, 1998
Randomised comparison of addition of autologous bone-marrow transplantation to intensive chemotherapy for acute myeloid leukaemia in first remission: results of MRC AML 10 trial. UK Medical Research Council Adult and Children's Leukaemia Working PartiesA K Burnett, A H Goldstone, R M Stevens, et al.
Cancer Genetics and Cytogenetics|April 1, 1988
Translocation 5;21 and interstitial deletion of chromosome 7 in a case of chronic myelomonocytic leukemiaP D Sherrington, E Nacheva, P Fischer, et al.
British Journal of Haematology|November 1, 1991
Prognostic importance of Sudan Black positivity: a study of bone marrow slides from 1,386 patients with de novo acute myeloid leukaemiaC F Hoyle, R G Gray, K Wheatley, et al.
British Journal of Haematology|May 1, 1989
AML associated with previous cytotoxic therapy, MDS or myeloproliferative disorders: results from the MRC's 9th AML trialC F Hoyle, M de Bastos, K Wheatley, et al.
British Journal of Haematology|October 16, 1999
A simple, robust, validated and highly predictive index for the determination of risk-directed therapy in acute myeloid leukaemia derived from the MRC AML 10 trial. United Kingdom Medical Research Council's Adult and Childhood Leukaemia Working PartiesK Wheatley, A K Burnett, A H Goldstone, et al.
British Journal of Haematology|August 1, 1980
The association of eosinophilia with lymphoblastic leukaemia or lymphoma: a study of seven patientsD Catovsky, C Bernasconi, P J Verdonck, et al.
British Medical Journal (Clinical Research Ed.)|February 28, 1981
Long survival in acute myelogenous leukaemia: an international collaborative studyJ A Whittaker, P Reizenstein, S T Callender, et al.
Leukemia|January 1, 1996
Chemotherapy versus transplants for acute myelogenous leukemia in second remissionR P Gale, M M Horowitz, J K Rees, et al.
Pageof 4

Showing results (31-40 of 40) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 40 results.
British Journal of Haematology|February 1, 1984
8;21 translocation in acute granulocytic leukaemia: cytological, cytochemical and clinical featuresD M Swirsky, Y S Li, J G Matthews, et al.
Blood|April 1, 1997
Randomized comparison of DAT versus ADE as induction chemotherapy in children and younger adults with acute myeloid leukemia. Results of the Medical Research Council's 10th AML trial (MRC AML10). Adult and Childhood Leukaemia Working Parties of the Medical Research CouncilI M Hann, R F Stevens, A H Goldstone, et al.
Lancet (London, England)|March 21, 1998
Randomised comparison of addition of autologous bone-marrow transplantation to intensive chemotherapy for acute myeloid leukaemia in first remission: results of MRC AML 10 trial. UK Medical Research Council Adult and Children's Leukaemia Working PartiesA K Burnett, A H Goldstone, R M Stevens, et al.
Cancer Genetics and Cytogenetics|April 1, 1988
Translocation 5;21 and interstitial deletion of chromosome 7 in a case of chronic myelomonocytic leukemiaP D Sherrington, E Nacheva, P Fischer, et al.
British Journal of Haematology|November 1, 1991
Prognostic importance of Sudan Black positivity: a study of bone marrow slides from 1,386 patients with de novo acute myeloid leukaemiaC F Hoyle, R G Gray, K Wheatley, et al.
British Journal of Haematology|May 1, 1989
AML associated with previous cytotoxic therapy, MDS or myeloproliferative disorders: results from the MRC's 9th AML trialC F Hoyle, M de Bastos, K Wheatley, et al.
British Journal of Haematology|October 16, 1999
A simple, robust, validated and highly predictive index for the determination of risk-directed therapy in acute myeloid leukaemia derived from the MRC AML 10 trial. United Kingdom Medical Research Council's Adult and Childhood Leukaemia Working PartiesK Wheatley, A K Burnett, A H Goldstone, et al.
British Journal of Haematology|August 1, 1980
The association of eosinophilia with lymphoblastic leukaemia or lymphoma: a study of seven patientsD Catovsky, C Bernasconi, P J Verdonck, et al.
British Medical Journal (Clinical Research Ed.)|February 28, 1981
Long survival in acute myelogenous leukaemia: an international collaborative studyJ A Whittaker, P Reizenstein, S T Callender, et al.
Leukemia|January 1, 1996
Chemotherapy versus transplants for acute myelogenous leukemia in second remissionR P Gale, M M Horowitz, J K Rees, et al.
Pageof 4